The Latest
-
Boston Scientific recalls carotid stents over manufacturing defect
The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.
-
Tempus inks $81M Paige buyout to support AI model development
CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.
-
Medtech firms shuffle execs in 2025
Top leaders at Intuitive, Boston Scientific, Dexcom and others changed roles this year. Read MedTech Dive’s roundup for all the details.
-
MedTech Europe sounds alarm over impact of US-EU tariffs on patients
The trade group wants the U.S. to eliminate tariffs on medical technologies, warning that “patients cannot be collateral damage in trade tensions.”
-
Ransomware attack on DaVita exposes data from 2.7M
The data breach is one of the largest healthcare incidents reported to federal regulators this year.
-
The robotic surgery market battle is heating up
After a busy summer of surgical robotics news, check out MedTech Dive’s roundup of coverage in the space.
-
AdvaMed urges Dr. Oz to speed Medicare coverage of breakthrough devices
The medtech trade group wants the CMS to take “bold action” to cut the lag between FDA authorization of devices and Medicare coverage.
-
More than 1,100 devices have received the FDA’s breakthrough designation
The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.
-
CMS initiative targets undocumented immigrants in Medicaid
CMS will provide states monthly reports of beneficiaries whose citizenship or immigration status cannot be confirmed. States are expected to take “appropriate actions” including limiting coverage, the agency said.
-
US, EU agree to terms of framework trade pact
The two trading partners documented provisions of a deal that would set a 15% tariff on many EU imports, including cars, auto parts, pharmaceuticals and semiconductors.
-
Q&A
How Aktiia built the first over-the-counter cuffless blood pressure monitor
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
-
Retrieved from Luna Health on August 20, 2025
Luna Health raises $23.6M for tiny insulin patch pump
The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.
-
NeuroOne gains FDA clearance for trigeminal nerve ablation
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
-
Medtronic adds 2 board seats, forms special committees
CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.